Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Enhanced hyperoxidation of peroxiredoxin 2 and peroxiredoxin 3 in the presence of bicarbonate/CO2.

Peskin AV, Pace PE, Winterbourn CC.

Free Radic Biol Med. 2019 Sep 12. pii: S0891-5849(19)31036-6. doi: 10.1016/j.freeradbiomed.2019.09.010. [Epub ahead of print]

PMID:
31521665
2.

Bicarbonate is essential for protein-tyrosine phosphatase 1B (PTP1B) oxidation and cellular signaling through EGF-triggered phosphorylation cascades.

Dagnell M, Cheng Q, Rizvi SHM, Pace PE, Boivin B, Winterbourn CC, Arnér ESJ.

J Biol Chem. 2019 Aug 16;294(33):12330-12338. doi: 10.1074/jbc.RA119.009001. Epub 2019 Jun 13.

3.

Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides.

Bresciani A, Ontoria JM, Biancofiore I, Cellucci A, Ciammaichella A, Di Marco A, Ferrigno F, Francone A, Malancona S, Monteagudo E, Nizi E, Pace P, Ponzi S, Rossetti I, Veneziano M, Summa V, Harper S.

ACS Med Chem Lett. 2018 Nov 27;10(4):481-486. doi: 10.1021/acsmedchemlett.8b00517. eCollection 2019 Apr 11.

PMID:
30996783
4.

Peroxiredoxin expression and redox status in neutrophils and HL-60 cells.

de Souza LF, Pearson AG, Pace PE, Dafre AL, Hampton MB, Meotti FC, Winterbourn CC.

Free Radic Biol Med. 2019 May 1;135:227-234. doi: 10.1016/j.freeradbiomed.2019.03.007. Epub 2019 Mar 9.

PMID:
30862546
5.

Why we shouldn't use the term "illegal migrant".

Ingleby D, Bhopal RS, Gruer L, Krasnik A, Pace P, Petrova-Benedict R.

BMJ. 2018 Nov 20;363:k4885. doi: 10.1136/bmj.k4885. No abstract available.

PMID:
30459154
6.

Peroxiredoxin interaction with the cytoskeletal-regulatory protein CRMP2: Investigation of a putative redox relay.

Pace PE, Peskin AV, Konigstorfer A, Jasoni CJ, Winterbourn CC, Hampton MB.

Free Radic Biol Med. 2018 Dec;129:383-393. doi: 10.1016/j.freeradbiomed.2018.10.407. Epub 2018 Oct 10.

PMID:
30315937
7.

Development of the medication adherence estimation and differentiation scale (MEDS).

Athavale AS, Bentley JP, Banahan BF 3rd, McCaffrey DJ 3rd, Pace PF, Vorhies DW.

Curr Med Res Opin. 2019 Apr;35(4):577-585. doi: 10.1080/03007995.2018.1512478. Epub 2018 Sep 12.

PMID:
30106315
8.

Seabird species vary in behavioural response to drone census.

Brisson-Curadeau É, Bird D, Burke C, Fifield DA, Pace P, Sherley RB, Elliott KH.

Sci Rep. 2017 Dec 20;7(1):17884. doi: 10.1038/s41598-017-18202-3.

9.

Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H2O2 exposure.

Dagnell M, Pace PE, Cheng Q, Frijhoff J, Östman A, Arnér ESJ, Hampton MB, Winterbourn CC.

J Biol Chem. 2017 Sep 1;292(35):14371-14380. doi: 10.1074/jbc.M117.793745. Epub 2017 Jul 6.

10.

Preliminary development of the Medication Nonpersistence Scale.

Athavale AS, Bentley JP, Banahan BF 3rd, McCaffrey DJ 3rd, Pace PF.

J Am Pharm Assoc (2003). 2017 May - Jun;57(3):389-394.e1. doi: 10.1016/j.japh.2017.01.014. Epub 2017 Mar 6.

PMID:
28279599
11.

Glutathionylation of the Active Site Cysteines of Peroxiredoxin 2 and Recycling by Glutaredoxin.

Peskin AV, Pace PE, Behring JB, Paton LN, Soethoudt M, Bachschmid MM, Winterbourn CC.

J Biol Chem. 2016 Feb 5;291(6):3053-62. doi: 10.1074/jbc.M115.692798. Epub 2015 Nov 24.

12.

Interaction of adenanthin with glutathione and thiol enzymes: selectivity for thioredoxin reductase and inhibition of peroxiredoxin recycling.

Soethoudt M, Peskin AV, Dickerhof N, Paton LN, Pace PE, Winterbourn CC.

Free Radic Biol Med. 2014 Dec;77:331-9. doi: 10.1016/j.freeradbiomed.2014.09.025. Epub 2014 Oct 5.

PMID:
25289458
13.

Store and prescription characteristics associated with primary medication nonadherence.

Jackson TH, Bentley JP, McCaffrey DJ 3rd, Pace P, Holmes E, West-Strum D.

J Manag Care Spec Pharm. 2014 Aug;20(8):824-32.

14.

Mala-movida: late bed-timing and wake-up induce malnutrition and underweight in youngsters.

Trovato G, Pace P, Martines GF, Brischetto D.

Chronobiol Int. 2014 Oct;31(8):945-6. doi: 10.3109/07420528.2014.931414. Epub 2014 Jun 25. No abstract available.

PMID:
24963991
15.

Perceived body weight status of youngsters interferes with headache in obese and non-obese subjects.

Trovato G, Brischetto D, Pace P, Fabio Martines G.

Headache. 2014 Jun;54(6):1062-3. doi: 10.1111/head.12374. No abstract available.

PMID:
24916593
16.

Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.

Trovato FM, Catalano D, Martines GF, Pace P, Trovato GM.

Clin Nutr. 2015 Feb;34(1):86-8. doi: 10.1016/j.clnu.2014.01.018. Epub 2014 Jan 31.

PMID:
24529325
17.

Enrichment specificity of micro and nano-sized titanium and zirconium dioxides particles in phosphopeptide mapping.

Vilasi A, Fiume I, Pace P, Rossi M, Pocsfalvi G.

J Mass Spectrom. 2013 Nov;48(11):1188-98. doi: 10.1002/jms.3254.

PMID:
24259207
18.

Mediterranean diet: Relationship with anxiety and depression.

Trovato GM, Catalano D, Martines GF, Pace P, Trovato FM.

Ann Neurol. 2014 Apr;75(4):613. doi: 10.1002/ana.23991. Epub 2014 Apr 2. No abstract available.

PMID:
23929593
19.

Mediterranean diet and physical activity: an intervention study. Does olive oil exercise the body through the mind?

Catalano D, Trovato GM, Pace P, Martines GF, Trovato FM.

Int J Cardiol. 2013 Oct 9;168(4):4408-9. doi: 10.1016/j.ijcard.2013.05.034. Epub 2013 May 26. No abstract available.

PMID:
23714600
20.

Hyperoxidized peroxiredoxin 2 interacts with the protein disulfide- isomerase ERp46.

Pace PE, Peskin AV, Han MH, Hampton MB, Winterbourn CC.

Biochem J. 2013 Aug 1;453(3):475-85. doi: 10.1042/BJ20130030.

PMID:
23713588
21.

Hyperoxidation of peroxiredoxins 2 and 3: rate constants for the reactions of the sulfenic acid of the peroxidatic cysteine.

Peskin AV, Dickerhof N, Poynton RA, Paton LN, Pace PE, Hampton MB, Winterbourn CC.

J Biol Chem. 2013 May 17;288(20):14170-7. doi: 10.1074/jbc.M113.460881. Epub 2013 Mar 29.

22.

Stress, abdominal obesity and intrarenal resistive index in essential hypertension.

Trovato GM, Pace P, Martines GF, Trovato FM, Pirri C, Catalano D.

Clin Ter. 2012 Jul;163(4):299-305.

PMID:
23007813
23.

Gender, lifestyles, illness perception and stress in stable atrial fibrillation.

Trovato GM, Pace P, Cangemi E, Martines GF, Trovato FM, Catalano D.

Clin Ter. 2012 Jul;163(4):281-6.

PMID:
23007810
24.

Medication adherence among recipients with chronic diseases enrolled in a state Medicaid program.

Khanna R, Pace PF, Mahabaleshwarkar R, Basak RS, Datar M, Banahan BF.

Popul Health Manag. 2012 Oct;15(5):253-60. doi: 10.1089/pop.2011.0069. Epub 2012 Mar 8.

PMID:
22401152
25.

Renal resistive index and parathyroid hormone relationship with renal function in nondiabetic patients.

Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Catalano D.

Endocr Res. 2012;37(2):47-58. doi: 10.3109/07435800.2011.625513. Epub 2011 Oct 18.

PMID:
22007967
26.

Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance.

Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Garozzo A, Castro A, Catalano D.

Dig Dis Sci. 2012 Feb;57(2):535-44. doi: 10.1007/s10620-011-1903-8. Epub 2011 Sep 28.

PMID:
21953137
27.

Model for the exceptional reactivity of peroxiredoxins 2 and 3 with hydrogen peroxide: a kinetic and computational study.

Nagy P, Karton A, Betz A, Peskin AV, Pace P, O'Reilly RJ, Hampton MB, Radom L, Winterbourn CC.

J Biol Chem. 2011 May 20;286(20):18048-55. doi: 10.1074/jbc.M111.232355. Epub 2011 Mar 8.

28.

Pain assessment in fibromyalgia and rheumatoid arthritis: influence of physical activity and illness perception.

Trovato GM, Pace P, Salerno S, Trovato FM, Catalano D.

Clin Ter. 2010;161(4):335-9.

PMID:
20931156
29.

Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs.

Yang Y, Thumula V, Pace PF, Banahan BF 3rd, Wilkin NE, Lobb WB.

J Am Pharm Assoc (2003). 2010 Jul-Aug;50(4):527-31. doi: 10.1331/JAPhA.2010.09071.

PMID:
20621872
30.

Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway.

Pace P, Mosedale G, Hodskinson MR, Rosado IV, Sivasubramaniam M, Patel KJ.

Science. 2010 Jul 9;329(5988):219-23. doi: 10.1126/science.1192277. Epub 2010 Jun 10.

31.

Elective coronary stent patients: preinterventional functional status and clinical-instrumental assessment.

Trovato GM, Pace P, Tamburino C, Garufi G, Martines GF, Pirri C, Trovato F, Catalano D.

Heart Vessels. 2010 Mar;25(2):82-6. doi: 10.1007/s00380-009-1163-0. Epub 2010 Mar 26.

PMID:
20339967
32.

High-risk diabetic patients in Medicare Part D programs: are they getting the recommended ACEI/ARB therapy?

Yang Y, Thumula V, Pace PF, Banahan BF 3rd, Wilkin NE, Lobb WB.

J Gen Intern Med. 2010 Apr;25(4):298-304. doi: 10.1007/s11606-009-1242-z. Epub 2010 Jan 28.

33.

Novel P2-P4 macrocyclic inhibitors of HCV NS3/4A protease by P3 succinamide fragment depeptidization strategy.

Pompei M, Di Francesco ME, Pesci S, Koch U, Vignetti SE, Veneziano M, Pace P, Summa V.

Bioorg Med Chem Lett. 2010 Jan 1;20(1):168-74. doi: 10.1016/j.bmcl.2009.11.005. Epub 2009 Nov 10.

PMID:
19932966
34.

Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.

Yang Y, Thumula V, Pace PF, Banahan BF 3rd, Wilkin NE, Lobb WB.

Clin Ther. 2009 Oct;31(10):2178-88; discussion 2150-1. doi: 10.1016/j.clinthera.2009.10.002.

PMID:
19922889
35.

Novel macrocyclic inhibitors of hepatitis C NS3/4A protease featuring a 2-amino-1,3-thiazole as a P4 carbamate replacement.

Di Francesco ME, Dessole G, Nizi E, Pace P, Koch U, Fiore F, Pesci S, Di Muzio J, Monteagudo E, Rowley M, Summa V.

J Med Chem. 2009 Nov 26;52(22):7014-28. doi: 10.1021/jm900524b.

PMID:
19856919
36.

The effects of hyperoxia exposure on lung function and pulmonary surfactant in a rat model of acute lung injury.

Pace PW, Yao LJ, Wilson JX, Possmayer F, Veldhuizen RA, Lewis JF.

Exp Lung Res. 2009 Jun;35(5):380-98.

PMID:
19842840
37.

Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI.

Alpi AF, Pace PE, Babu MM, Patel KJ.

Mol Cell. 2008 Dec 26;32(6):767-77. doi: 10.1016/j.molcel.2008.12.003.

38.

Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.

Summa V, Petrocchi A, Bonelli F, Crescenzi B, Donghi M, Ferrara M, Fiore F, Gardelli C, Gonzalez Paz O, Hazuda DJ, Jones P, Kinzel O, Laufer R, Monteagudo E, Muraglia E, Nizi E, Orvieto F, Pace P, Pescatore G, Scarpelli R, Stillmock K, Witmer MV, Rowley M.

J Med Chem. 2008 Sep 25;51(18):5843-55. doi: 10.1021/jm800245z.

PMID:
18763751
39.

Integrase inhibitors for the treatment of HIV infection.

Pace P, Rowley M.

Curr Opin Drug Discov Devel. 2008 Jul;11(4):471-9. Review.

PMID:
18600564
40.

4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.

Pace P, Spieser SA, Summa V.

Bioorg Med Chem Lett. 2008 Jul 15;18(14):3865-9. doi: 10.1016/j.bmcl.2008.06.056. Epub 2008 Jun 20.

PMID:
18595690
41.

Development of 2-t butyl-N-methyl pyrimidones as potent inhibitors of HIV integrase.

Di Francesco ME, Pace P, Fiore F, Naimo F, Bonelli F, Rowley M, Summa V.

Bioorg Med Chem Lett. 2008 Apr 15;18(8):2709-13. doi: 10.1016/j.bmcl.2008.03.017. Epub 2008 Mar 10.

PMID:
18362069
42.

Deubiquitination of FANCD2 is required for DNA crosslink repair.

Oestergaard VH, Langevin F, Kuiken HJ, Pace P, Niedzwiedz W, Simpson LJ, Ohzeki M, Takata M, Sale JE, Patel KJ.

Mol Cell. 2007 Dec 14;28(5):798-809.

43.

Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidones.

Gardelli C, Nizi E, Muraglia E, Crescenzi B, Ferrara M, Orvieto F, Pace P, Pescatore G, Poma M, Ferreira Mdel R, Scarpelli R, Homnick CF, Ikemoto N, Alfieri A, Verdirame M, Bonelli F, Paz OG, Taliani M, Monteagudo E, Pesci S, Laufer R, Felock P, Stillmock KA, Hazuda D, Rowley M, Summa V.

J Med Chem. 2007 Oct 4;50(20):4953-75. Epub 2007 Sep 8.

PMID:
17824681
44.

Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors.

Pace P, Di Francesco ME, Gardelli C, Harper S, Muraglia E, Nizi E, Orvieto F, Petrocchi A, Poma M, Rowley M, Scarpelli R, Laufer R, Gonzalez Paz O, Monteagudo E, Bonelli F, Hazuda D, Stillmock KA, Summa V.

J Med Chem. 2007 May 3;50(9):2225-39. Epub 2007 Apr 12.

PMID:
17428043
45.

4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species.

Summa V, Petrocchi A, Matassa VG, Gardelli C, Muraglia E, Rowley M, Paz OG, Laufer R, Monteagudo E, Pace P.

J Med Chem. 2006 Nov 16;49(23):6646-9.

PMID:
17154493
46.

Analysis of changes in optical fibers during arc-fusion splicing by use of quantitative phase imaging.

Dragomir NM, Ampen-Lassen E, Baxter GW, Pace P, Huntington ST, Farrell PM, Stevenson AJ, Roberts A.

Microsc Res Tech. 2006 Nov;69(11):847-51.

PMID:
17029239
47.

Evaluation of a primary care-oriented brief counselling intervention for obesity with and without orlistat.

Poston WS, Haddock CK, Pinkston MM, Pace P, Reeves RS, Karakoc N, Jones P, Foreyt JP.

J Intern Med. 2006 Oct;260(4):388-98.

48.

Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cannabinoid receptor inverse agonists/antagonists.

Muccioli GG, Wouters J, Charlier C, Scriba GK, Pizza T, Di Pace P, De Martino P, Poppitz W, Poupaert JH, Lambert DM.

J Med Chem. 2006 Feb 9;49(3):872-82.

PMID:
16451053
49.

The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.

Mosedale G, Niedzwiedz W, Alpi A, Perrina F, Pereira-Leal JB, Johnson M, Langevin F, Pace P, Patel KJ.

Nat Struct Mol Biol. 2005 Sep;12(9):763-71. Epub 2005 Aug 21.

PMID:
16116434
50.

Weight loss with meal replacement and meal replacement plus snacks: a randomized trial.

Poston WS, Haddock CK, Pinkston MM, Pace P, Karakoc ND, Reeves RS, Foreyt JP.

Int J Obes (Lond). 2005 Sep;29(9):1107-14.

PMID:
15925955

Supplemental Content

Support Center